Global Genito-Urinary Drugs Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

1 Mar, 2021

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities (organizations, sole traders and partnerships) that produce genito-urinary drugs to treat genito-urinary diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. This industry includes establishments that produce infertility drugs, hormonal contraceptives, erectile dysfunction drugs and hormonal replacement drugs to treat infertility, infections and prevent pregnancy. It also consists of establishments which produce drugs for benign prostatic hypertrophy, drugs for urinary incontinence and overactive bladder, diuretics to treat urinary calculi, glomerular disorders and other urinary disorders.

Global Genito-Urinary Drugs Market Size And Drivers:

The global genito-urinary drugs market is expected to grow from $49.24 billion in 2020 to $53.78 billion in 2021 at a compound annual growth rate (CAGR) of 9.2%. The market is expected to reach $63.95 billion in 2025 at a CAGR of 4%. The aging population profile of most countries contributed to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally, contributed significantly to the growth of the market during the historic period.

Request For A Sample For The Global Genito-Urinary Drugs Market Report:

Trends In The Global Genito-Urinary Drugs Market

Pharmaceutical companies are investing in development of new class drugs for treating overactive bladders (OAB). Earlier anti-muscarinic agents have been used for the treatment of OAB. Going forward, the market is expected to be driven by a new class of drug known as beta-3 adrenergic agonists that has been increasingly used to treat OAB. Beta-3 adrenergic agonists are drugs which cause the bladder muscles to relax without causing side effects such as dry mouth.

Global Genito-Urinary Drugs Market Segments:
The global genito-urinary drugs market is further segmented based on type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type:Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics.
By Distribution Channel:Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration:Oral, Parenteral, Others.
By Drug Classification:Branded Drugs, Generic Drugs.
By Mode Of Purchase:Prescription-Based Drugs, Over-The-Counter Drugs.
By Geography:The global genito-urinary drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Among these regions, North America is the largest region in the global genito-urinary drugs market, accounting for 55% of the total market.

Read More On The Report For The Global Genito-Urinary Drugs Market At:

Genito-Urinary Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides genito-urinary drugs market overviews, analyzes and forecasts market size and growth for the global genito-urinary drugs market, genito-urinary drugs market share, genito-urinary drugs market players, genito-urinary drugs market segments and geographies, genito-urinary drugs market’s leading competitors’ revenues, profiles and market shares. The genito-urinary drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.